Trial Profile
A single-center cohort study to evaluate rituximab for induction and maintenance therapy in granulomatosis with polyangiitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Granulomatosis
- Focus Therapeutic Use
- 14 Dec 2015 New trial record